Author

Anna V. Zinkovskaya

Observed names: A. V. Zinkovskaya, A. Zinkovskaya, A.V. Zinkovskaya, Anna Zinkovskaya, Зинковская А. В.

Institution: R-Pharm (Russia)

Observed institution: R-Pharm (Russia)

ORCID: 0000-0002-7028-0496

Observed ORCID: 0000-0002-7028-0496

OpenAlex ID: A5060461449

Testing and validation of the Russian version of quality of life questionnaire in patients with GERD – GERD-HRQL

2020 · T. I. Ionova, A. V. Zinkovskaya, et al. · Terapevticheskii arkhiv · 4

Bioequivalence Study of Generic Molnupiravir in Healthy Volunteers

2023 · V. B. Vasilyuk, A. Yu. Boroduleva, et al. · Pharmacy & Pharmacology · 2

Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Interim Results of Russian Prospective Multicenter Trial RU-SKI

2018 · Anna Petrova, Ekaterina Chelysheva, et al. · Blood · 2

Efficacy of nivolumab (Nivo) as 2+ line treatment and quality of life (QoL) in advanced refractory non-small cell lung cancer (NSCLC) patients: Interim results of observational prospective study.

2018 · Konstantin K. Laktionov, Alla L. Arzumanyan, et al. · Journal of Clinical Oncology · 2

Olokizumab reduces the risks of death in hospitalized patients with moderate and severe COVID-19

2022 · E.V. Tavlueva, A.E. Markarov, et al. · Infectious diseases News Opinions Training · 1

Efficacy of Nivolumab (nwo) During 2+ Line Treatment and Quality of Life in Patients With Advanced Refractory Non-small Cell Lung Cancer: Interim Results of Prospective Observational Study

2019 · Konstantin Laktionov, Alla Arzumanyan, et al. · Voprosy Onkologii · 1

Bioequivalence study of generic nirmatrelvir in healthy volunteers

2023 · R. A. Oseshnyuk, A. G. Nikiforova, et al. · Pharmacy & Pharmacology

Quality of Life (QoL) and Clinical Outcomes in Patients with Relapsed/Refractory Multiple Myeloma (RRMM) Receiving Ixazomib-Lenalidomide-Dexamethasone (IRd) in a Real-World Setting

2020 · Tatyana Ionova, Elena Ado, et al. · Blood

Multicenter observational prospective study of nivolumab (Nivo) as 2+ line treatment in advanced refractory NSCLC pts: Clinical and quality of life outcomes.

2019 · Rashida Orlova, Konstantin Laktionov, et al. · Journal of Clinical Oncology

The effect of medical social rehabilitation on quality of life in children with brain tumors: Interim results of observational prospective study.

2018 · Grigory Ja. Tseitlin, Alexander G. Rumyantsev, et al. · Journal of Clinical Oncology

P1.01-056 Quality of Life and Clinical Outcomes of Nivolumab as 2+ Line Treatment in Advanced Refractory NSCLC Pts: Interim Analysis

2017 · T. Ionova, A. Arzumanyan, et al. · Journal of Thoracic Oncology

Works count: 13

Citation count: 12

H-index: 2

I10-index: